Apollo Global Management is exploring an IPO for Tenneco Inc.'s India business, potentially valuing it at around $2 billion. Tenneco, acquired by Apollo for $7.1 billion in 2022, could raise $400 ...

Eliza Labs, the developer behind ai16z, has published a white paper outlining a vision for Web3-native artificial intelligence agents, the Web3 AI project said on Jan. 14. The 20-page document ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. According to Luma, Ray2 can distinguish interactions between different objects and object ...

SAN FRANCISCO, Jan 14 (Reuters) - The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's ...

Currently, Aragen promoters Gunupati Aparna Reddy and Davinder Singh Brar, former Ranbaxy CEO, own 33.7% each while Goldman Sachs has about 31.3%. The rest is held by an employee welfare trust and ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...

Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma Marlborough, Massachusetts--(Newsfile Corp. - January 13, 2025) - Phio Pharmaceuticals Corp. (NASDAQ ...

Bristol Myers Squibb Pharmaceuticals (pomalidomide) (confidentiality agreement not signed, not participating) Dr. Reddy's Laboratories UK (bortezomib) (confidentiality agreement not signed, not ...

Dr. Reddy's Laboratories UK (bortezomib) (dexamethasone) (confidentiality agreement not signed, not participating) Glenmark Pharmaceuticals Europe (dexamethasone, lenalidomide) (dexamethasone) ...

Indian generic drug-makers such as Ranbaxy Laboratories charge domestic customers 1%-2% of what US consumers pay, says BusinessWeek. Telecoms firms offer mobile services at tariffs that make ...